Targeting Homologous Recombination Repair in Cancer - DNA Repair in Cancer Therapy - page 154

289. Kalb R, Duerr M, Wagner M, et al. Lack of sensitivity of primary
Fanconi's anemia fibroblasts to UV and ionizing radiation. Radiat
Res 2004;161(3):318 e 25.
290. Arlett CF, Harcourt SA. Survey of radiosensitivity in a variety of
human cell strains. Cancer Res 1980;40(3):926 e 32.
291. Duckworth-Rysiecki G, Taylor AM. Effects of ionizing radiation
on cells from Fanconi's anemia patients. Cancer Res 1985;45(1):
416 e 20.
292. Fornace Jr AJ, Little JB, Weichselbaum RR. DNA repair in a Fan-
coni's anemia fibroblast cell strain. Biochim Biophys Acta 1979;
561(1):99 e 109.
293. Weichselbaum RR, Nove J, Little JB. X-ray sensitivity of fifty-three
human diploid fibroblast cell strains from patients with charac-
terized genetic disorders. Cancer Res 1980;40(3):920 e 5.
294. Djuzenova C, Flentje M, Plowman PN. Radiation response in
vitro of fibroblasts from a fanconi anemia patient with marked
clinical radiosensitivity. Strahlenther Onkol 2004;180(12):789 e 97.
295. Kuhnert VM, Kachnic LA, Li L, et al. FANCD2-deficient human
fibroblasts are hypersensitive to ionising radiation at oxygen
concentrations of 0% and 3% but not under normoxic conditions.
Int J Radiat Biol 2009;85(6):523 e 31.
296. Sprong D, Janssen HL, Vens C, Begg AC. Resistance of hypoxic
cells to ionizing radiation is influenced by homologous recom-
bination status. Int J Radiat Oncol Biol Phys 2006;64(2):562 e 72.
297. Davies KJ. Oxidative stress, antioxidant defenses, and damage
removal, repair, and replacement systems. IUBMB Life 2000;
50(4-5):279 e 89.
298. Durante M, Loeffler JS. Charged particles in radiation oncology.
Nat Rev Clin Oncol 2010;7(1):37 e 43.
299. Hada M, Sutherland BM. Spectrum of complex DNA damages
depends on the incident radiation. Radiat Res 2006;165(2):223 e 30.
300. Kundrat P, Stewart RD. On the biophysical interpretation of lethal
DNA lesions induced by ionising radiation. Radiat Prot Dosimetry
2006;122(1-4):169 e 72.
301. Kraft G, Kramer M, Scholz MLET. Track structure and models.
A review. Radiat Environ Biophys 1992;31(3):161 e 80.
302. Zafar F, Seidler SB, Kronenberg A, Schild D, Wiese C. Homolo-
gous recombination contributes to the repair of DNA double-
strand breaks induced by high-energy iron ions. Radiat Res 2010;
173(1):27 e 39.
303. Frankenberg-Schwager M, Gebauer A, Koppe C, Wolf H, Pralle E,
Frankenberg D. Single-strand annealing, conservative homolo-
gous recombination, nonhomologous DNA end joining, and the
cell cycle-dependent repair of DNA double-strand breaks
induced by sparsely or densely ionizing radiation. Radiat Res
2009;171(3):265 e 73.
304. Rostek C, Turner EL, Robbins M, et al. Involvement of homolo-
gous recombination repair after proton-induced DNA damage.
Mutagenesis 2008;23(2):119 e 29.
305. Dikomey E, Dahm-Daphi J, Brammer I, Martensen R, Kaina B.
Correlation between cellular radiosensitivity and non-repaired
double-strand breaks studied in nine mammalian cell lines. Int J
Radiat Biol 1998;73(3):269 e 78.
306. Powell C, Mikropoulos C, Kaye SB, et al. Pre-clinical and clinical
evaluation of PARP inhibitors as tumour-specific radiosensitisers.
Cancer Treat Rev 2010;36(7):566 e 75.
307. Bryant HE, Petermann E, Schultz N, et al. PARP is activated at
stalled forks to mediate Mre11-dependent replication restart and
recombination. EMBO J 2009;28(17):2601 e 15.
308. Chalmers AJ, Lakshman M, Chan N, Bristow RG. Poly(ADP-
ribose) polymerase inhibition as a model for synthetic lethality in
developing radiation oncology targets. Semin Radiat Oncol 2010;
20(4):274 e 81.
309. Dungey FA, Loser DA, Chalmers AJ. Replication-dependent
radiosensitization of human glioma cells by inhibition of

poly(ADP-Ribose) polymerase: mechanisms and therapeutic
potential. Int J Radiat Oncol Biol Phys 2008;72(4):1188 e 97.
310. Harper JV, Anderson JA, O'Neill P. Radiation induced DNA
DSBs: Contribution from stalled replication forks? DNA Repair
(Amst) 2010;9(8):907 e 13.
311. Noel G, Godon C, Fernet M, Giocanti N, Megnin-Chanet F,
Favaudon V. Radiosensitization by the poly(ADP-ribose) poly-
merase inhibitor 4-amino-1,8-naphthalimide is specific of the
S phase of the cell cycle and involves arrest of DNA synthesis.
Mol Cancer Ther 2006;5(3):564 e 74.
312. Godon C, Cordelieres FP, Biard D, et al. PARP inhibition versus
PARP-1 silencing: different outcomes in terms of single-strand
break repair and radiation susceptibility. Nucleic Acids Res 2008;
36(13):4454 e 64.
313. Neijenhuis S, Verwijs-Janssen M, van den Broek LJ, Begg AC,
Vens C. Targeted radiosensitization of cells expressing truncated
DNA polymerase {beta}. Cancer Res 2010;70(21):8706 e 14.
314. Neijenhuis S, Verwijs-Janssen M, Kasten-Pisula U, et al. Mecha-
nism of cell killing after ionizing radiation by a dominant nega-
tive DNA polymerase beta. DNA Repair (Amst) 2009;8(3):336 e 46.
315. Starcevic D, Dalal S, Sweasy JB. Is there a link between DNA
polymerase beta and cancer? Cell Cycle 2004;3(8):998 e 1001.
316. Yuan ZM, Huang Y, Ishiko T, et al. Regulation of Rad51 function
by c-Abl in response to DNA damage. J Biol Chem 1998;273(7):
3799 e 802.
317. Chen G, Yuan SS, Liu W, et al. Radiation-induced assembly of
Rad51 and Rad52 recombination complex requires ATM and
c-Abl. J Biol Chem 1999;274(18):12748 e 52.
318. Yuan SS, Chang HL, Lee EY. Ionizing radiation-induced Rad51
nuclear focus formation is cell cycle-regulated and defective in
both ATM(-/-) and c-Abl(-/-) cells. Mutat Res 2003;525(1-2):
85 e 92.
319. Shimizu H, Popova M, Fleury F, et al. c-ABL tyrosine kinase
stabilizes RAD51 chromatin association. Biochem Biophys Res
Commun 2009;382(2):286 e 91.
320. Slupianek A, Schmutte C, Tombline G, et al. BCR/ABL regulates
mammalian RecA homologs, resulting in drug resistance. Mol
Cell 2001;8(4):795 e 806.
321. Aloyz R, Grzywacz K, Xu ZY, Loignon M, Alaoui-Jamali MA,
Panasci L. Imatinib sensitizes CLL lymphocytes to chlorambucil.
Leukemia 2004;18(3):409 e 14.
322. Choudhury A, Zhao H, Jalali F, et al. Targeting homologous
recombination using imatinib results in enhanced tumor cell
chemosensitivity and radiosensitivity. Mol Cancer Ther 2009;8(1):
203 e 13.
323. Russell JS, Brady K, Burgan WE, et al. Gleevec-mediated inhibi-
tion of Rad51 expression and enhancement of tumor cell radio-
sensitivity. Cancer Res 2003;63(21):7377 e 83.
324. Shimamura T, Shapiro GI. Heat shock protein 90 inhibition in
lung cancer. J Thorac Oncol 2008;3(6 Suppl. 2):S152 e 9.
325. Oda T, Hayano T, Miyaso H, Takahashi N, Yamashita T. Hsp90
regulates the Fanconi anemia DNA damage response pathway.
Blood 2007;109(11):5016 e 26.
326. Camphausen K, Tofilon PJ. Inhibition of Hsp90: a multitarget
approach to radiosensitization. Clin Cancer Res 2007;13(15 Pt. 1):
4326 e 30.
327. Noguchi M, Yu D, Hirayama R, et al. Inhibition of homologous
recombination repair in irradiated tumor cells pretreated with
Hsp90 inhibitor 17-allylamino-17-demethoxygeldanamycin. Bio-
chem Biophys Res Commun 2006;351(3):658 e 63.
328. Lee DH, Goldberg AL. Proteasome inhibitors: valuable new tools
for cell biologists. Trends Cell Biol 1998;8(10):397 e 403.
329. von Mikecz A. The nuclear ubiquitin-proteasome system. J Cell
Sci 2006;119(Pt. 10):1977 e 84.